NCT04303858
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04303858
Title A Study to Evaluate Safety and Anti-Tumor Activity of RO7284755 Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries POL | NLD | ESP | DNK | BEL

Facility Status City State Zip Country Details
Cliniques Universitaires St-Luc Brussels 1200 Belgium Details
UZ Leuven Gasthuisberg Leuven 3000 Belgium Details
Herlev Hospital Herlev 2730 Denmark Details
Rigshospitalet København Ø 2100 Denmark Details
NKI/AvL Amsterdam 1066 CX Netherlands Details
Erasmus MC Rotterdam 3015 GD Netherlands Details
Uniwersyteckie Centrum Kliniczne Gdansk 80-214 Poland Details
Narodowy Instytut Onkologii im. M. Sklodowskiej-Curie Warsaw 02-781 Poland Details
Clinica Universitaria de Navarra Pamplona Navarre 31008 Spain Details
Hospital del Mar Barcelona 08003 Spain Details
Vall d'Hebron Institute of Oncology (VHIO), Barcelona Barcelona 08035 Spain Details
Hospital Clinic Barcelona Barcelona 08036 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field